Puretech Health Plc Stock Performance
| PRTC Stock | USD 16.71 1.13 6.33% |
The company holds a Beta of -0.21, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PureTech Health are expected to decrease at a much lower rate. During the bear market, PureTech Health is likely to outperform the market. At this point, PureTech Health PLC has a negative expected return of -0.26%. Please make sure to check PureTech Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if PureTech Health PLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days PureTech Health PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (6.39) | Five Day Return (4.36) | Year To Date Return (14.23) | Ten Year Return (56.60) | All Time Return (56.60) |
1 | PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference | 01/08/2025 |
2 | Short Interest in PureTech Health plc Increases By 77.7 | 01/17/2025 |
3 | PureTech Health stock hits 52-week low at 16.71 amid market challenges - Investing.com UK | 03/20/2025 |
| Begin Period Cash Flow | 149.9 M |
PureTech |
PureTech Health Relative Risk vs. Return Landscape
If you would invest 1,992 in PureTech Health PLC on December 24, 2024 and sell it today you would lose (321.00) from holding PureTech Health PLC or give up 16.11% of portfolio value over 90 days. PureTech Health PLC is currently does not generate positive expected returns and assumes 2.6362% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than PureTech, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PureTech Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PureTech Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PureTech Health PLC, and traders can use it to determine the average amount a PureTech Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0979
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRTC |
Estimated Market Risk
| 2.64 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PureTech Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PureTech Health by adding PureTech Health to a well-diversified portfolio.
PureTech Health Fundamentals Growth
PureTech Stock prices reflect investors' perceptions of the future prospects and financial health of PureTech Health, and PureTech Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PureTech Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.13 | ||||
| Operating Margin | (230.55) % | ||||
| Current Valuation | (75.65 M) | ||||
| Shares Outstanding | 24.02 M | ||||
| Price To Book | 1.27 X | ||||
| Price To Sales | 877.23 X | ||||
| Revenue | 3.33 M | ||||
| Gross Profit | (81.55 M) | ||||
| EBITDA | (11.63 M) | ||||
| Net Income | (65.7 M) | ||||
| Cash And Equivalents | 368.03 M | ||||
| Cash Per Share | 12.84 X | ||||
| Total Debt | 25.34 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 2.54 X | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (105.92 M) | ||||
| Earnings Per Share | (3.00) X | ||||
| Market Capitalization | 410.54 M | ||||
| Total Asset | 693.97 M | ||||
| Retained Earnings | 83.82 M | ||||
| Working Capital | 295.83 M | ||||
About PureTech Health Performance
By analyzing PureTech Health's fundamental ratios, stakeholders can gain valuable insights into PureTech Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PureTech Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PureTech Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.09) | |
| Return On Capital Employed | (0.26) | (0.25) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.16) | (0.15) |
Things to note about PureTech Health PLC performance evaluation
Checking the ongoing alerts about PureTech Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PureTech Health PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PureTech Health PLC generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 3.33 M. Net Loss for the year was (65.7 M) with loss before overhead, payroll, taxes, and interest of (81.55 M). | |
| PureTech Health PLC currently holds about 368.03 M in cash with (105.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. | |
| PureTech Health PLC has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: PureTech Health stock hits 52-week low at 16.71 amid market challenges - Investing.com UK |
- Analyzing PureTech Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PureTech Health's stock is overvalued or undervalued compared to its peers.
- Examining PureTech Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PureTech Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PureTech Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PureTech Health's stock. These opinions can provide insight into PureTech Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PureTech Stock analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |